The Lessons of Vioxx — Drug Safety and Sales

In May, the Government Reform Committee of the U.S. House of Representatives held a hearing that explored how drugs with serious safety issues can remain so popular for so long. Representative Henry Waxman describes how what was learned illuminated the practices that pharmaceutical manufacturers use to promote their products to physicians.